USPSTF recommendations you may have missed amid the breast cancer controversy
Campos-Outcalt, D.
Journal of Family Practice 59(5): 276-280
2010
ISSN/ISBN: 0094-3509 PMID: 20544048 Document Number: 646436
The USPSTF recommends aspirin for the prevention of stroke and heart attack for those at risk, and screening for major depression and childhood obesity.
Document emailed within 1 workday
Related Documents
Smith, D.K.; Demetriou, T.; Weber, C. 2019: Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer Journal of Family Practice 68(3): 146-151Owens, D.K. 2017: Aspirin for the Prevention of Cardiovascular Disease and Colorectal Cancer: New Recommendations from the USPSTF American Family Physician 95(4): 222-223
Davisson, L. 2016: USPSTF Breast Cancer Screening Guidelines West Virginia Medical Journal 112(6): 29-31
Campos-Outcalt, D. 2016: 8 USPSTF recommendations FPs need to know about Journal of Family Practice 65(5): 338-341
Brown, S. 2007: More controversy over breast cancer rates in the USA Menopause International 13(2): 51-52
Henrich, J.B. 1992: The postmenopausal estrogen/breast cancer controversy JAMA 268(14): 1900-1902
Snyder, G.M.; Sielsch, E.C.; Reville, B. 1998: The controversy of hormone-replacement therapy in breast cancer survivors Oncology Nursing Forum 25(4): 699-706; Quiz: 707-708
Kuriyama, S.; Tsuji, I. 2004: Current controversy on the effectiveness of mammographic screening for breast cancer in western nations Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(2): 158-162
Layne, G.P. 2016: Screening Mammography: Controversy and Recommendations West Virginia Medical Journal 112(6): 26-29
Penney, G.; Brechin, S.; Glasier, A.; Bigrigg, A. 2005: Missed contraceptive pill recommendations Lancet 366(9493): 1264
Guilbert, E.; Black, A.; Dunn, S.; Senikas, V.; Bérubé, J.; Charbonneau, L.; Guilbert, Éd.; Leboeuf, M.; McConnery, C.; Gilbert, A.ée.; Risi, C.; Roy, G.èv.; Steben, M.; Wagner, M.-S.; Aggarwal, A.; Burnett, M.; Davis, V.J.; Fisher, W.A.; Lamont, J.A.; Levinsky, E.; MacKinnon, K.; McLeod, N.L.; Pellizzari, R.; Wagner, M.-S.; Wells, T. 2008: Missed hormonal contraceptives: new recommendations Journal of Obstetrics and Gynaecology Canada: Jogc 30(11): 1050-1062
Madduri, S.D. 2018: USPSTF Update of Guidelines on Early Detection of Prostate Cancer Missouri Medicine 115(4): 337
Hungr, C.; Sanchez-Varela, V.; Bober, S.L. 2017: Self-Image and Sexuality Issues among Young Women with Breast Cancer: Practical Recommendations Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 69(2): 114-122
Tomek, R.; Oresković, L.B.ć; Vrdoljak, E.; Soldić, Z.; Podolski, P.; Plestina, S.; Gugić, D.; Vojnović, Z.; Mise, B.P.; Tomić, S.; Fajdić, J.; Vrdoljak, D.V.; Drinković, I.; Brkljacić, B.; Mustać, E. 2012: Clinical recommendations for diagnosis, treatment and monitoring of patients with invasive breast cancer Lijecnicki Vjesnik 134(1-2): 1-5
Sabnis, S.S.; Pomeranz, A.J.; Lye, P.S.; Amateau, M.M. 1998: Do missed opportunities stay missed? a 6-month follow-up of missed vaccine opportunities in inner city Milwaukee children Pediatrics 101(5): E5
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Merkatz, R.B. 1993: The breast-implant controversy New England Journal of Medicine 328(10): 733
Balaton, A.L.; Coindre, J.M.; Collin, F.; Ettore, F.; Fiche, M.; Jacquemier, J.; Le Doussal, V.; Mandard, A.M.; Mathieu, M.C.; Migeon, C.; Simony-Lafontaine, J.; Treilleux, I.; Verriele, V.; Vilain, M.O.; Zafrani, B. 1996: Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology Annales de Pathologie 16(2): 144-148
Hernández-Bronchud, M. 1996: Hereditary predisposition to breast cancer: assessment of genetic risk and recommendations for the clinical follow-up of high-risk cases Medicina Clinica 107(10): 383-387
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510